Treatment of agitation in dementia - a systematic review

Dublin Core

Title

Treatment of agitation in dementia - a systematic review

Subject

Dementia, Systematic review, Agitation

Description

Abstract
Dementia, including Alzheimer’s disease (AD), affects millions worldwide, leading to cognitive decline, memory
loss, and behavioral disturbances. Agitation, a common symptom, poses significant challenges for patients and
caregivers. This systematic review evaluates pharmacological and non-pharmacological interventions for managing

agitation in dementia. Nine clinical studies were analyzed, encompassing medications like brexpiprazole and non-
pharmacological approaches such as music therapy and digital care programs. Pharmacological treatments showed

mixed efficacy and safety profiles, with brexpiprazole demonstrating dose-dependent benefits and mirtazapine
associating with higher mortality rates. Non-pharmacological interventions exhibited promising results in reducing
agitation without adverse effects. The review underscores the importance of personalized care strategies tailored
to individual patient needs and preferences to enhance treatment efficacy and quality of life, highlighting the shift
toward holistic, individualized care.
Keywords Dementia, Systematic review, Agitation

Creator

Misha Choudry1

, Murdoc Gould2

and Latha Ganti3,4*

Source

https://doi.org/10.1186/s12245-025-00902-7

Date

2025

Contributor

Peri Irawan

Format

pdf

Language

english

Type

text

Files

Citation

Misha Choudry1 , Murdoc Gould2 and Latha Ganti3,4*, “Treatment of agitation in dementia - a systematic review,” Repository Horizon University Indonesia, accessed April 11, 2026, https://repository.horizon.ac.id/items/show/12808.